Maria Kueirislene Amâncio Ferreira

Maria Kueirislene Amâncio Ferreira

Auto-generated profile, based on publicly available information

Maria Kueirislene Amâncio Ferreira

Programa de Pós-graduação em Ciências Naturais Universidade Estadual do Ceará Fortaleza CE Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
FMFrancisco Rogenio da Silva Mendes
Francisco Rogenio da Silva Mendes
ASAntonio Wlisses da Silva
Antonio Wlisses da Silva
MFMaria Kueirislene Amâncio Ferreira
Maria Kueirislene Amâncio Ferreira
EREmanuela de Lima Rebouças
Emanuela de Lima Rebouças
IBItalo Moura Barbosa
Italo Moura Barbosa
Helcio Silva Dos SantosHelcio Silva Dos Santos
Helcio Silva Dos Santos
The prevalence of anxiety is a significant public health problem, being the 24th leading cause of disability in individuals affected by this disorder. In this context, chalcones, a flavonoid subclass obtained from natural or synthetic sources, interact with central nervous system (CNS) receptors at the same binding site as benzodiazepines, the primary drugs used in the treatment of anxiety. Thus, our study investigates the anxiolytic effect of synthetic chalcones derived from the natural product 2-hydroxy-3,4,6-trimethoxyacetophenone isolated from Croton anisodontus Müll.Arg. in modulating anxiolytic activity via GABAergic and serotoninergic neurotransmission in an adult zebrafish model. Chalcones 1 and 2 were non-toxic to adult zebrafish and showed anxiolytic activity via GABAA receptors. Chalcone 2 also had its anxiolytic action reversed by the antagonist granisetron, indicating the participation of serotonergic receptors 5HTR3A/3B in the anxiolytic effect. In addition, molecular docking results showed that chalcones have a higher affinity for the GABAA receptor than DZP and binding in the same region of the DZP binding site, indicating a similar effect to the drug. Furthermore, the interaction of chalcones with GABAA and 5-HT3A receptors demonstrates the anxiolytic effect potential of these molecules. Communicated by Ramaswamy H. Sarma

28 August 2023 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
MCMatheus Campelo
Matheus Campelo
JNJoão Francisco Câmara Neto
João Francisco Câmara Neto
ÁSÁlamo Lourenço de Souza
Álamo Lourenço de Souza
MFMaria Kueirislene Amâncio Ferreira
Maria Kueirislene Amâncio Ferreira
Helcio Silva Dos SantosHelcio Silva Dos Santos
Helcio Silva Dos Santos
MRMaria Elenir Nobre Pinho Ribeiro
Maria Elenir Nobre Pinho Ribeiro

25 January 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
TGTatiana Rodrigues Garcia
Tatiana Rodrigues Garcia
PFPaulo de Tarso Cavalcante Freire
Paulo de Tarso Cavalcante Freire
ASAntonio Wlisses da Silva
Antonio Wlisses da Silva
MFMaria Kueirislene Amâncio Ferreira
Maria Kueirislene Amâncio Ferreira
EREmanuela de Lima Rebouças
Emanuela de Lima Rebouças
Helcio Silva Dos SantosHelcio Silva Dos Santos
Helcio Silva Dos Santos
Anxiety and epilepsy affect millions of people worldwide, and the treatment of these pathologies involves the use of Benzodiazepines, drugs that have serious adverse effects such as dependence and sedation, so the discovery of new anxiolytic and antiepileptic drugs are necessary. Many routes for synthesizing ibuprofen derivatives have been developed, and these derivatives have shown promising pharmacological effects. Therefore, this study aims to evaluate its anxiolytic and anticonvulsant effect against the adult Zebrafish animal model of Ibuprofen (IBUACT) and its interaction with the GABAergic receptor through in silico studies. The light/dark preference test (Scototaxis test) was used to evaluate the anxiolytic behavior of adult Zebrafish acutely treated with IBUACT and Diazepam, and their anticonvulsant effects were investigated through the pentylenetetrazol (PTZ)-induced seizure model. Animals treated with IBUACT showed anxiolytic behavior similar to Diazepam, and pretreatment with flumazenil reversed this behavior. PTZ-induced seizures were delayed by IBUACT in all three stages and were shown to bind strongly in the Diazepam region of GABAA. In addition, this work presents evidence of new pharmacological applications of ibuprofen derivative in pathologies of the central nervous system (CNS), opening the horizon for new studies. Communicated by Ramaswamy H. Sarma

1 January 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
JAJoão Ronielly Campêlo Araújo
João Ronielly Campêlo Araújo
ACAdriana Rolim Campos
Adriana Rolim Campos
MDMarina de Barros Mamede Vidal Damasceno
Marina de Barros Mamede Vidal Damasceno
SSSacha Aubrey Alves Rodrigues Santos
Sacha Aubrey Alves Rodrigues Santos
MFMaria Kueirislene Amâncio Ferreira
Maria Kueirislene Amâncio Ferreira
AMAna Cristina Monteiro-Moreira
Ana Cristina Monteiro-Moreira
Background: Plant lectins have shown promising biological activities in the central nervous system (CNS). Objective: This study evaluated the effect of DAL, a lectin isolated from the seeds of the Dioclea altissima species, having binding affinity to D-glucose or D-mannose residues, on mice behavior. Methods: Mice (n=6/group) were treated (i.p.) with DAL (0.25, 0.5 or 1 mg/kg) or vehicle and subjected to several tests (open field/OFT, marble-burying/MBT, hole-board/HBT, elevated plus maze/PMT, tail suspension/TST, forced swimming/FST or rotarod/RRT). Pizotifen, cyproheptadine, flumazenil, L-NAME, 7-NI, L-arginine or yohimbine were administered 15 min before DAL (0.5 mg/kg) and the animals were evaluated on PMT. It was also verified whether the DAL effect depended on its structural integrity and ability to interact with carbohydrates. Results: The results showed there were no neurobehavioral changes in the mice at the RRT, FST and locomotion in the OFT. DAL (0.25, 0.5 or 1 mg/kg) increased the behavior of grooming and rearing in the OFT, head dips in the HBT, pedalling in the TST and decreased the number of marbles hidden in the MBT. In the PMT, DAL (0.25, 0.5 and 1 mg/kg) and Diazepam increased the frequency of entries in the open arms and the time of permanence in the open arms without affecting the locomotor activity. The effect of DAL was dependent on carbohydrate interaction and protein structure integrity and it prevented by pizotifen, cyproheptadine, flumazenil, L-NAME and 7-NI, but not by L-arginine or yohimbine. Conclusion: DAL was found to have an anxiolytic-like effect mediated by the 5-HT and GABAergic receptors and NO pathway.

8 April 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
JMJorge Fernando Silva de Menezes
Jorge Fernando Silva de Menezes
ASAndrei Marcelino Sá Pires Silva
Andrei Marcelino Sá Pires Silva
EAEdna Aparecida Faria de Almeida
Edna Aparecida Faria de Almeida
ASAnanias Freire da Silva
Ananias Freire da Silva
JLJulia Morais Bomfim De Lima
Julia Morais Bomfim De Lima
AFAluisio Marques da Fonseca
Aluisio Marques da Fonseca
Anxiety-related mental health problems are estimated at 3.6% globally, benzodiazepines (BZDs) are the class of drugs indicated for the treatment of anxiety, including lorazepam and diazepam. However, concerns have been raised about the short- and long-term risks associated with BZDs. Therefore, despite anxiolytic and antidepressant drugs, there is a need to develop more effective pharmacotherapies with fewer side effects than existing drugs. The present work reported the synthesis, anxiolytic activity, mechanism of action in Adult Zebrafish (Danio rerio) and in silico study of a europium metallic complex with Lapachol, [Eu(DBM)3. LAP]. Each animal (n = 6/group) was treated intraperitoneally (i.p.; 20 µL) with the synthesized complex (4, 20 and 40 mg/Kg) and with the vehicle (DMSO 3%; 20 µL), being submitted to the tests of locomotor activity and 96h acute toxicity. The light/dark test was also performed, and the serotonergic mechanism (5-HT) was evaluated through the antagonists of the 5-HTR1, 5-HTR2A/2C and 5-HTR3A/3B receptors. The complex was characterized using spectrometric techniques, and the anxiolytic effect of complex may be involved the neuromodulation of receptors 5-HT3A/3B, since the pre-treatment with pizotifen and cyproheptadine did not block the anxiolytic effect of [Eu(DBM)3. LAP], unlike fluoxetine had its anxiolytic effect reversed. In addition, molecular docking showed interaction between the [Eu(DBM)3. LAP] and 5HT3A receptor with binding energy −7.8 kcal/mol and the ADMET study showed that complex has low toxic risk. It is expected that the beginning of this study will allow the application of the new anxiolytic drugs, given the pharmacological potential of the lapachol complex. Communicated by Ramaswamy H. Sarma

28 February 2024 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
ELElder Luis Lima Leite
Elder Luis Lima Leite
ASAna Sheila de Queiroz Souza
Ana Sheila de Queiroz Souza
PRPaulo Ribeiro
Paulo Ribeiro
RPRita de Cássia Alves Pereira
Rita de Cássia Alves Pereira
NMNatalia Florencio Martins
Natalia Florencio Martins
KCKirley Marques Canuto
Kirley Marques Canuto